Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: AIDS Behav. 2012 Nov;16(8):2257–2266. doi: 10.1007/s10461-011-0072-2

Figure 1.

Figure 1

HIV+/BD+ participants evidence worse 30-day MEMS antiretroviral adherence rates as compared to HIV+/BD− participants. Note: Thick bar represents Median; error bars include 95% of the distribution; significance determined via Wilcoxon Rank Sum Test.